114 related articles for article (PubMed ID: 9114462)
1. Adrenomedullin (16-31) has pressor activity in the rat but not the cat.
Champion HC; Friedman DE; Lambert DG; Murphy WA; Coy DH; Kadowitz PJ
Peptides; 1997; 18(1):133-6. PubMed ID: 9114462
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine release mediates pressor effects of adrenomedullin-(15-22) in the rat.
Champion HC; Fry RC; Murphy WA; Coy DH; Kadowitz PJ
Hypertension; 1996 Dec; 28(6):1041-6. PubMed ID: 8952594
[TBL] [Abstract][Full Text] [Related]
3. Proadrenomedullin NH2-terminal peptide (PAMP)(12-20) has vasodepressor activity in the rat and cat.
Fry RC; Champion HC; Lawrence TC; Murphy WA; Coy DH; Kadowitz PJ
Life Sci; 1997; 60(10):PL161-7. PubMed ID: 9064471
[TBL] [Abstract][Full Text] [Related]
4. Analysis of responses to human synthetic adrenomedullin and calcitonin gene-related peptides in the hindlimb vascular bed of the cat.
Champion HC; Akers DL; Santiago JA; Lambert DG; McNamara DB; Kadowitz PJ
Mol Cell Biochem; 1997 Nov; 176(1-2):5-11. PubMed ID: 9406138
[TBL] [Abstract][Full Text] [Related]
5. Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat.
Champion HC; Lambert DG; McWilliams SM; Shah MK; Murphy WA; Coy DH; Kadowitz PJ
Regul Pept; 1997 Jun; 70(2-3):161-5. PubMed ID: 9272628
[TBL] [Abstract][Full Text] [Related]
6. Proadrenomedullin NH2-terminal 20 peptide has cAMP-mediated vasodilator activity in the mesenteric vascular bed of the cat.
Champion HC; Erickson CC; Simoneaux ML; Bivalacqua TJ; Murphy WA; Coy DH; Kadowitz PJ
Peptides; 1996; 17(8):1379-87. PubMed ID: 8971935
[TBL] [Abstract][Full Text] [Related]
7. Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats.
Gumusel B; Hao Q; Hyman AL; Kadowitz PJ; Champion HC; Chang JK; Mehta JL; Lippton H
Am J Physiol; 1998 Apr; 274(4):H1255-63. PubMed ID: 9575929
[TBL] [Abstract][Full Text] [Related]
8. Proadrenomedullin NH2-terminal 20 peptide has direct vasodilator activity in the cat.
Champion HC; Murphy WA; Coy DH; Kadowitz PJ
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1047-54. PubMed ID: 9140000
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator effect of human adrenomedullin(13-52) on hypertensive rats.
Tian Q; Zhao D; Tan DY; Zhao YT; Li QH; Qiu JX; Song LW; Gong CN; Yang J; Lippton H
Can J Physiol Pharmacol; 1995 Jul; 73(7):1065-9. PubMed ID: 8846402
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of adrenomedullin, an adrenomedullin analog, and CGRP in the pulmonary vascular bed of the cat and rat.
Nossaman BD; Feng CJ; Cheng DY; Dewitt BJ; Coy DH; Murphy WA; Kadowitz PJ
Life Sci; 1995; 56(3):PL63-6. PubMed ID: 7823766
[TBL] [Abstract][Full Text] [Related]
11. [MPR14]-rADM(14-50), a novel analog of adrenomedullin, possesses potent vasodilator activity in the hindlimb vascular bed of the cat.
Champion HC; Duperier CD; Fitzgerald WE; Lambert DG; Murphy WA; Coy DH; Kadowitz PJ
Life Sci; 1996; 59(1):PL1-7. PubMed ID: 8684260
[TBL] [Abstract][Full Text] [Related]
12. Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat.
Champion HC; Pierce RL; Bivalacqua TJ; Murphy WA; Coy DH; Kadowitz PJ
Peptides; 2001 Sep; 22(9):1427-34. PubMed ID: 11514024
[TBL] [Abstract][Full Text] [Related]
13. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
Adams MD; Earnhardt JT; Dewey WL; Harris LS
J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
Bolt GR; Itoh H; Lederis K; MacCannell KL
J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
[TBL] [Abstract][Full Text] [Related]
15. Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa.
Heise A; Kroneberg G
Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):285-300. PubMed ID: 4147968
[No Abstract] [Full Text] [Related]
16. Effects of norepinephrine on alpha-subtype receptors in the feline pulmonary vascular bed.
Kaye AD; Hoover JM; Baber SR; Ibrahim IN; Fields AM
Crit Care Med; 2004 Nov; 32(11):2300-3. PubMed ID: 15640645
[TBL] [Abstract][Full Text] [Related]
17. Comparison of responses to adrenomedullin and adrenomedullin analogs in the mesenteric vascular bed of the cat.
Santiago JA; Garrison E; Purnell WL; Smith RE; Champion HC; Coy DH; Murphy WA; Kadowitz PJ
Eur J Pharmacol; 1995 Jan; 272(1):115-8. PubMed ID: 7713143
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin inhibits the pressor effects and decrease in renal blood flow induced by norepinephrine or angiotensin II in anesthetized rats.
Minami K; Segawa K; Uezono Y; Shiga Y; Shiraishi M; Ogata J; Shigematsu A
Jpn J Pharmacol; 2001 Jun; 86(2):159-64. PubMed ID: 11459117
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive effects of adrenotensin and its interactions with adrenomedullin.
Zhou L; Qiu Z; Ye C; Di L; Liu X; Tang C; Zhao Y
Chin Med J (Engl); 2000 Mar; 113(3):269-71. PubMed ID: 11775262
[TBL] [Abstract][Full Text] [Related]
20. An adrenomedullin fragment retains the systemic vasodepressor activity of rat adrenomedullin.
Lin B; Gao Y; Chang JK; Heaton J; Hyman A; Lippton H
Eur J Pharmacol; 1994 Jul; 260(1):1-4. PubMed ID: 7957618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
